🩺 Renal Replacement Therapy Initiation Indication (CRRT/RRT)
Renal replacement therapy (RRT) initiation and modality decision in acute kidney injury, separating emergent indications from trend-based timing.
Clinical takeaway
Do not apply chronic-CKD BUN/creatinine thresholds to the critically ill; emergent indications and overall trajectory drive timing (original synthesis · not guideline verbatim).
Loading calculator…
Paste the link in Slack, Teams, X, or LinkedIn — the preview image comes from this page’s Open Graph card.
When to use
Use to identify emergent RRT indications and to choose between continuous (CRRT) and intermittent (IHD) modalities based on hemodynamics.
How it works
Any emergent indication (refractory hyperkalemia, severe acidosis pH < 7.1, refractory volume overload, uremic complications/severe azotemia, dialyzable poisoning) initiates RRT; without these, decide early vs late by trends. CRRT preferred when hemodynamically unstable/brain-injured.
Key points
- Do not apply chronic-CKD BUN/creatinine thresholds to the critically ill; emergent indications and overall trajectory drive timing (original synthesis · not guideline verbatim).
- Trials of early vs delayed initiation (AKIKI, IDEAL-ICU, STARRT-AKI) have not shown consistent benefit to routine early start.
- CRRT offers smoother hemodynamics and ICP control; IHD corrects hyperkalemia faster in stable patients.
References
- KDIGO Clinical Practice Guideline for AKI. Kidney Int Suppl 2012.
- STARRT-AKI Investigators. N Engl J Med 2020.
Decision support for licensed clinicians only; not a substitute for clinical judgement, diagnosis or local protocols.
Worked calculation
The values below come from this tool's own example placeholders and are computed server-side with the formula shown on this page, so the arithmetic can be checked quickly. It demonstrates how to substitute values only — it is not clinical advice and not a real case.
| Refractory hyperkalemia (K > 6.5 or rapidly rising, hard to control medically) | No |
|---|---|
| Refractory severe metabolic acidosis (pH < 7.1) | No |
| Refractory volume overload/pulmonary edema (diuretic-resistant) | No |
| Uremic symptoms (encephalopathy/pericarditis/bleeding) or severe azotemia | No |
| Dialyzable toxin/drug poisoning (e.g. lithium, methanol, ethylene glycol, salicylate) | No |
| Hemodynamically unstable (needs vasopressors/brain injury/raised ICP) | No |
→RRT initiationNo emergent indication
- Determination：No emergent indication above: in the critically ill, do not wait for traditional CKD thresholds; decide early vs late initiation by volume/metabolic trends and overall clinical picture (evidence for early benefit is inconsistent)
- Modality choice：IHD or CRRT (IHD acceptable if hemodynamically stable; IHD is faster for rapid hyperkalemia correction)
- Management direction：Continue medical management (hyperkalemia, acidosis, volume), monitor urine output/electrolytes/acid-base and azotemia trends
| Refractory hyperkalemia (K > 6.5 or rapidly rising, hard to control medically) | Yes |
|---|---|
| Refractory severe metabolic acidosis (pH < 7.1) | Yes |
| Refractory volume overload/pulmonary edema (diuretic-resistant) | Yes |
| Uremic symptoms (encephalopathy/pericarditis/bleeding) or severe azotemia | Yes |
| Dialyzable toxin/drug poisoning (e.g. lithium, methanol, ethylene glycol, salicylate) | Yes |
| Hemodynamically unstable (needs vasopressors/brain injury/raised ICP) | Yes |
→RRT initiationEmergent indication present
- Determination：Emergent indication present: refractory hyperkalemia, severe acidosis (pH < 7.1), volume overload/pulmonary edema, uremia/severe azotemia, dialyzable poisoning → start renal replacement therapy
- Modality choice：CRRT (continuous; preferred over intermittent hemodialysis when hemodynamically unstable/brain injury/raised ICP, reducing blood-pressure and ICP swings)
- Management direction：Start RRT promptly and correct triggers concurrently; hemodynamic instability favors CRRT, effluent dose 20–25 mL/kg/h; anticoagulation preferably regional citrate (if no contraindication)
Frequently asked questions
- What is Renal Replacement Therapy Initiation Indication (CRRT/RRT)?
- Renal replacement therapy (RRT) initiation and modality decision in acute kidney injury, separating emergent indications from trend-based timing.
- How is Renal Replacement Therapy Initiation Indication (CRRT/RRT) calculated? What is the core formula?
- Any emergent indication (refractory hyperkalemia, severe acidosis pH < 7.1, refractory volume overload, uremic complications/severe azotemia, dialyzable poisoning) initiates RRT; without these, decide early vs late by trends. CRRT preferred when hemodynamically unstable/brain-injured.
- When is Renal Replacement Therapy Initiation Indication (CRRT/RRT) used?
- Use to identify emergent RRT indications and to choose between continuous (CRRT) and intermittent (IHD) modalities based on hemodynamics.
- What are the key clinical points for Renal Replacement Therapy Initiation Indication (CRRT/RRT)?
- Do not apply chronic-CKD BUN/creatinine thresholds to the critically ill; emergent indications and overall trajectory drive timing (original synthesis · not guideline verbatim). Trials of early vs delayed initiation (AKIKI, IDEAL-ICU, STARRT-AKI) have not shown consistent benefit to routine early start. CRRT offers smoother hemodynamics and ICP control; IHD corrects hyperkalemia faster in stable patients.
- What are the limits and cautions when using Renal Replacement Therapy Initiation Indication (CRRT/RRT)?
- For licensed clinicians and clinical researchers. Interpret results with history, investigations and local protocols; not a diagnosis or prescription, and not a substitute for multidisciplinary decision-making or local guidelines.
- How is Renal Replacement Therapy Initiation Indication (CRRT/RRT) calculated in practice? Can you show a worked example?
- Inputs: Refractory hyperkalemia (K > 6.5 or rapidly rising, hard to control medically) No, Refractory severe metabolic acidosis (pH < 7.1) No, Refractory volume overload/pulmonary edema (diuretic-resistant) No, Uremic symptoms (encephalopathy/pericarditis/bleeding) or severe azotemia No, Dialyzable toxin/drug poisoning (e.g. lithium, methanol, ethylene glycol, salicylate) No, Hemodynamically unstable (needs vasopressors/brain injury/raised ICP) No → Result: RRT initiation No emergent indication（Determination: No emergent indication above: in the critically ill, do not wait for traditional CKD thresholds; decide early vs late initiation by volume/metabolic trends and overall clinical picture (evidence for early benefit is inconsistent), Modality choice: IHD or CRRT (IHD acceptable if hemodynamically stable; IHD is faster for rapid hyperkalemia correction), Management direction: Continue medical management (hyperkalemia, acidosis, volume), monitor urine output/electrolytes/acid-base and azotemia trends） Inputs: Refractory hyperkalemia (K > 6.5 or rapidly rising, hard to control medically) Yes, Refractory severe metabolic acidosis (pH < 7.1) Yes, Refractory volume overload/pulmonary edema (diuretic-resistant) Yes, Uremic symptoms (encephalopathy/pericarditis/bleeding) or severe azotemia Yes, Dialyzable toxin/drug poisoning (e.g. lithium, methanol, ethylene glycol, salicylate) Yes, Hemodynamically unstable (needs vasopressors/brain injury/raised ICP) Yes → Result: RRT initiation Emergent indication present（Determination: Emergent indication present: refractory hyperkalemia, severe acidosis (pH < 7.1), volume overload/pulmonary edema, uremia/severe azotemia, dialyzable poisoning → start renal replacement therapy, Modality choice: CRRT (continuous; preferred over intermittent hemodialysis when hemodynamically unstable/brain injury/raised ICP, reducing blood-pressure and ICP swings), Management direction: Start RRT promptly and correct triggers concurrently; hemodynamic instability favors CRRT, effluent dose 20–25 mL/kg/h; anticoagulation preferably regional citrate (if no contraindication)）